{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T12:13:35Z","timestamp":1785932015320,"version":"3.56.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Stomatology Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jormas.2025.102575","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T06:34:17Z","timestamp":1758954857000},"page":"102575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and clinicopathological correlation of BRAF V600E mutations in ameloblastoma: A PCR study from a tertiary centre in South India"],"prefix":"10.1016","volume":"127","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2559-3119","authenticated-orcid":false,"given":"Logeswari","family":"Jayamani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavitha","family":"Bottu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena Dennis","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganthimathy","family":"Sekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jormas.2025.102575_bib0001","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/odi.12646","article-title":"Ameloblastoma: current etiopathological concepts and management","volume":"24","author":"Effiom","year":"2018","journal-title":"Oral Dis"},{"key":"10.1016\/j.jormas.2025.102575_bib0002","series-title":"Ameloblastoma.[Updated 2023 Jan 20]. StatPearls [Internet]. Treasure Island (FL)","author":"Palanisamy","year":"2023"},{"issue":"11","key":"10.1016\/j.jormas.2025.102575_bib0003","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.31557\/APJCP.2022.23.11.3601","article-title":"Prevalence and epidemiological profile of ameloblastoma in India: a systematic review and meta-analyses","volume":"23","author":"Ragunathan","year":"2022","journal-title":"Asian Pacific J Cancer Prevent: APJCP"},{"issue":"3","key":"10.1016\/j.jormas.2025.102575_bib0004","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijom.2015.12.016","article-title":"Recurrence rate following treatment for primary multicystic ameloblastoma: systematic review and meta-analysis","volume":"45","author":"Almeida","year":"2016","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"2","key":"10.1016\/j.jormas.2025.102575_bib0005","first-page":"168","article-title":"The World health organization classification of odontogenic lesions: a summary of the changes of the 2022 (5th) edition","volume":"38","author":"Soluk-Tekkesin","year":"2022","journal-title":"Turk J Pathol"},{"issue":"10","key":"10.1016\/j.jormas.2025.102575_bib0006","first-page":"e1656","article-title":"Precision medicine: sustained response to erdafitinib in FGFR2-mutant, multiply recurrent ameloblastoma","volume":"5","author":"Lawson-Michod","year":"2022","journal-title":"Cancer Rep"},{"issue":"22","key":"10.1016\/j.jormas.2025.102575_bib0007","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.3390\/cancers14225593","article-title":"BRAF V600E mutation in ameloblastoma: a systematic review and meta-analysis","volume":"14","author":"Mamat@ Yusof","year":"2022","journal-title":"Cancers"},{"issue":"21","key":"10.1016\/j.jormas.2025.102575_bib0008","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1158\/1078-0432.CCR-14-1069","article-title":"Activating FGFR2\u2013RAS\u2013BRAF mutations in ameloblastoma","volume":"20","author":"Brown","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.jormas.2025.102575_bib0009","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/jop.12851","article-title":"High prevalence of BRAF V600E mutations in Korean patients with ameloblastoma: clinicopathological significance and correlation with epithelial-mesenchymal transition","volume":"48","author":"Oh","year":"2019","journal-title":"J Oral Pathol Med"},{"issue":"3","key":"10.1016\/j.jormas.2025.102575_bib0010","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4132\/KoreanJPathol.2012.46.3.246","article-title":"Frequency of BRAF mutation and clinical relevance for primary melanomas","volume":"46","author":"Lee","year":"2012","journal-title":"Korean J Pathol"},{"issue":"1","key":"10.1016\/j.jormas.2025.102575_bib0011","doi-asserted-by":"crossref","DOI":"10.1080\/26895293.2023.2270170","article-title":"Clinicopathological relevance of BRAF and SMO mutations in Chinese patients with ameloblastoma","volume":"16","author":"Ruixue","year":"2023","journal-title":"All Life"},{"key":"10.1016\/j.jormas.2025.102575_bib0012","doi-asserted-by":"crossref","unstructured":"Evangelou Z., Zarachi A., Dumollard J.M., Peoc'h M., Komnos I., Kastanioudakis I., Karpathiou G. Maxillary ameloblastoma: a review with clinical, histological and prognostic data of a rare tumor. in vivo. 2020 ;34(5):2249\u201358.","DOI":"10.21873\/invivo.12035"},{"issue":"5","key":"10.1016\/j.jormas.2025.102575_bib0013","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00428-018-2305-5","article-title":"The landscape of genetic alterations in ameloblastomas relates to clinical features","volume":"472","author":"G\u00fcltekin","year":"2018","journal-title":"Virchows Archiv"},{"issue":"5","key":"10.1016\/j.jormas.2025.102575_bib0014","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/path.4317","article-title":"High frequency of BRAF V600E mutations in ameloblastoma","volume":"232","author":"Kurppa","year":"2014","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.jormas.2025.102575_bib0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.31557\/apjcb.2022.7.1.29-35","article-title":"Frequency of expression of BRAF V600E and epidermal growth factor receptor (EGFR) in Ameloblastoma","volume":"7","author":"Bashir","year":"2022","journal-title":"Asian Pacific J Cancer Biol"},{"issue":"4","key":"10.1016\/j.jormas.2025.102575_bib0016","doi-asserted-by":"crossref","first-page":"e509","DOI":"10.4317\/medoral.26493","article-title":"Frequency of BRAF V600E immunoexpression in ameloblastomas: a multi-institutional analysis of 86 cases in Latin America and comprehensive review of the literature","volume":"29","author":"Silveira","year":"2024","journal-title":"Med Oral, Patol Oral Cirug\u00eda Bucal"},{"issue":"11","key":"10.1016\/j.jormas.2025.102575_bib0017","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/s41379-022-01105-8","article-title":"The diagnostic utility of BRAF VE1 mutation-specific immunohistochemistry in ameloblastoma","volume":"35","author":"Mendez","year":"2022","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.jormas.2025.102575_bib0018","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/0022034518798810","article-title":"The mutational profile of unicystic ameloblastoma","volume":"98","author":"Heikinheimo","year":"2019","journal-title":"J Dent Res"},{"issue":"1","key":"10.1016\/j.jormas.2025.102575_bib0019","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41368-022-00170-8","article-title":"Identification of BRAF V600E mutation in odontogenic tumors by high-performance MALDI-TOF analysis","volume":"14","author":"Togni","year":"2022","journal-title":"Int J Oral Sci"},{"issue":"7","key":"10.1016\/j.jormas.2025.102575_bib0020","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ng.2986","article-title":"Identification of recurrent SMO and BRAF mutations in ameloblastomas","volume":"46","author":"Sweeney","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jormas.2025.102575_bib0021","first-page":"1","article-title":"Correlation of BRAF mutational status with clinical characteristics and survival outcomes of patients with ameloblastoma: the experience of 11 Italian centres","volume":"0","author":"Bonacina","year":"2021","journal-title":"J Clin Pathol"},{"issue":"10","key":"10.1016\/j.jormas.2025.102575_bib0022","article-title":"The role of BRAF inhibitors in the management of ameloblastoma: a literature review","volume":"15","author":"Malakar","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.jormas.2025.102575_bib0023","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1758834015616934","article-title":"Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy","volume":"8","author":"Eroglu","year":"2016","journal-title":"Therap Adv Med Oncol"},{"issue":"33","key":"10.1016\/j.jormas.2025.102575_bib0024","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1200\/JCO.2014.57.3535","article-title":"Combined BRAF (dabrafenib) and MEK inhibition (trametinib) in patients with BRAF V600-mutant melanoma experiencing progression with single-agent BRAF inhibitor","volume":"32","author":"Johnson","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jormas.2025.102575_bib0025","unstructured":"Grynberg S., Steinberg Y., Asher N., Ben-Betzalel G., Stoff R., Markel G., Shapira-Frommer R., Schachter J., Hirschhorn A. BRAF-targeted therapy for locally advanced ameloblastoma of the mandible: a potential neoadjuvant strategy."}],"container-title":["Journal of Stomatology Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468785525003611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468785525003611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T17:24:03Z","timestamp":1773163443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468785525003611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2468785525003611"],"URL":"https:\/\/doi.org\/10.1016\/j.jormas.2025.102575","relation":{},"ISSN":["2468-7855"],"issn-type":[{"value":"2468-7855","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and clinicopathological correlation of BRAF V600E mutations in ameloblastoma: A PCR study from a tertiary centre in South India","name":"articletitle","label":"Article Title"},{"value":"Journal of Stomatology Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jormas.2025.102575","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102575"}}